Operating profit before deduction of amortization: Nektar Therapeutics Inc. (NKTR)
Weak pricing power and a reliance on grants following program closures force Nektar Therapeutics (NKTR) to depend on early-stage tests. The operating cash flow reflects the business's sensitivity to external shocks, while 0.00 indicates the level of this metric. Brand stability is supported by a unique molecule modification platform and years of chemical engineering expertise in the fight against cancer.
nektar.com (NKTR) - metric breakdowns and financial figures
- stock value and consensus price forecast:
- company stock exchange capitalization indicators:
- shareholders' equity book value data:
- debt level and financial liquidity data:
- earnings and multiples data:
NKTR - Net Income|Future Net Profit Nektar Therapeutics|NKTR - P/E Multiple|Forward P/E Multiple Nektar Therapeutics Inc|NKTR - Price/Earnings to Growth Ratio|Business Value to Operating Income Before Depreciation Nektar|NKTR - Operating profit before deduction of amortization|Earnings per share for the trailing year Nektar Therapeutics|NKTR - Net earnings per share for the last 12 months|Year-over-year earnings per share growth rate for the last twelve months nektar.com|NKTR - Earnings growth in current year|Expected earnings per share trend next year Nektar Therapeutics
- sales and revenue indicators:
Analysis of all company metrics:Nektar Therapeutics - NKTR
The operational successes of Nektar Therapeutics (NKTR) determine its market value. By analyzing the absolute EBITDA level, an investor sees the real cash flow before depreciation and taxes. This metric strips the financial result of accounting adjustments, measuring the actual efficiency of fund generation. For a biotech platform, this is a critical marker of the ability to finance T-cell drug trials. The stability of this indicator confirms the business's resilience prior to concluding licensing deals.
Who Nektar Therapeutics competes with
Operating income before deduction of amortization argenx.com (ARGX)|BNTX - Profit before payment of interest, taxes and amortization|Abivax Corp (ABVX) - Operating profit before deduction of amortization|ADMA Corp (ADMA) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization Protagonist Therapeutics|Operating profit before deduction of amortization IMVT|Operating profit EBITDA kiniksa.com|Profit before payment of interest, taxes and amortization Grifols Group (GRFS)|Adaptive Biotechnologies Corporation - Operating profit before amortization|Operating profit EBITDA CLDX (celldex.com)|Aurinia Pharma (AUPH) - Profit before interest, taxes and amortization|BioCryst - Operating profit EBITDA|VERA: Profit before payment of interest, taxes and amortization|DNTH: Operating profit EBITDA|Pharvaris - Income before deduction of interest, taxes and amortization|ABCL (AbCellera Bio) - Operating profit EBITDA|Operating profit EBITDA Tourmaline|Operating profit EBITDA PGEN|PHAR (pharming.com) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA UPB (Upstream Pharma)|Operating income before deduction of amortization Zenas Biopharma, Inc. (ZBIO)|IMNM - Profit before payment of interest, taxes and amortization|Gossamer Corp (GOSS) - Operating profit before deduction of amortization|KALV (KalVista Pharmaceuticals Inc) - Operating profit before deduction of amortization|Operating profit before amortization SEPN|Profit before payment of interest, taxes and amortization Pieris Pharmaceuticals|Savara Inc (SVRA) - Operating income before deduction of amortization|Operating profit EBITDA RIGL|Operating income before deduction of amortization AnaptysBio Inc.|Operating profit EBITDA ATXS (Astria Therapeutics Inc)|enGene Holdings Inc. - Profit before payment of interest, taxes and amortization|RAPT - Profit before payment of interest, taxes and amortization|Income before deduction of interest, taxes and amortization JBIO (aerovatetx.com)|Aclaris (ACRS) - Profit before payment of interest, taxes and amortization|Kyverna - Income before deduction of interest, taxes and amortization|Operating profit before deduction of amortization TLSA|Profit before interest, taxes and amortization Cabaletta Bio CABA|Operating profit EBITDA VTYX|Theratechnologies (THTX) - Operating profit before depreciation charges|Avalo Therapeutics - Operating profit before deduction of amortization|Eledon Pharmaceuticals (ELDN) - Profit before interest, taxes and amortization|Agenus, Inc - Operating profit EBITDA|Profit before interest, taxes and amortization climbbio.com|ZURA (Zura Bio Limited) - Operating profit before deduction of amortization|aTyr (ATYR) - Operating profit EBITDA|Operating profit before deduction of amortization ADAG|IMA: Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Shattuck Therapeutics (STTK)|Operating profit before deduction of amortization Equillium EQ|Connect Biopharma Holdings Limited - Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization IMUX|ATRA - Profit before payment of interest, taxes and amortization|inflarx.de (IFRX) - Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization X4 Pharmaceuticals XFOR|ACET - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization celularity.com|INMB: Income before deduction of interest, taxes and amortization|Operating profit EBITDA BRNS|Operating profit EBITDA Kezar Life Sciences Inc (KZR)|Operating profit EBITDA SABS (SAB Biotherapeutics)|Operating profit EBITDA akaritx.com AKTX|Enlivex Therapeutics Ltd. - Operating profit EBITDA|QTTB - Operating profit EBITDA|GOVX (GeoVax Labs Inc) - Operating profit before deduction of amortization|Operating profit before deduction of amortization Edesa|IBIO (iBio, Inc.) - Operating profit EBITDA|CARM: Income before deduction of interest, taxes and amortization|Operating profit EBITDA XTLB|Operating profit before deduction of amortization Bolt Biotherapeutics, Inc. BOLT|Operating profit EBITDA HCWB (hcwbiologics.com)|Income before deduction of interest, taxes and amortization APVO|AIM ImmunoTech, Inc. - Operating profit EBITDA|ADTX (Aditxt Inc.) - Operating profit before amortization|GRI: Operating profit EBITDA|Operating profit before deduction of amortization XORTX Therapeutics|Operating profit before deduction of amortization HIND|REVB: Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization indaptusrx.com (INDP)|Operating profit before deduction of amortization Scinai Immunotherapeutics SCNI|Operating profit EBITDA CALI (CalciMedica Inc)|AFMD: Operating profit before amortization|ALLK - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization hookipapharma.com|IGMS: Operating profit EBITDA|ITOS: Company profit before taxes, interest and amortization|OCEA (Ocean Biomedical Corp) - Operating profit EBITDA|TCBP: Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Third Harmonic Bio, Inc (THRD)
